
=== PAGE 800 ===

784
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 30: Non Invasive Ventilation in Preterm Infants
1. Brett J. Manley, Peter G. Davis, Bradley A. Yoder, and Louise S. Owen. Noninvasive Respiratory Support. 
In Goldsmith’s assisted ventilation of the neonate (seventh edition). An evidence-based approach to 
newborn respiratory care Page 201- 220
2. Roehr CC, Yoder BA, Davis PG, Ives K. Evidence Support and Guidelines for Using Heated, Humidified, 
High-Flow Nasal Cannulae in Neonatology: Oxford Nasal High-Flow Therapy Meeting, 2015. Clin 
Perinatol. 2016 Dec;43(4): 693–705
3. Boel L, Hixson T, Brown L, Sage J, Kotecha S, Chakraborty M. Non-invasive respiratory support in 
preterm infants. Paediatr Respir Rev 2022 Sep; 43:53-59
4. Mahmoud RA, Schmalisch G, Oswal A, Christoph Roehr C. Non-invasive ventilatory support in neonates: 
An evidence-based update. Paediatr Respir Rev 2022 Dec; 44:11-18
5. Ramanathan R. Noninvasive Ventilation and High-Flow Nasal Cannula. In: Rajiv PK, Vidyasagar D, 
Lakshminrusimha. S (eds). Essentials of Neonatal Ventilation 1st Edition Copyright Elsevier India 2018.   
6. Rüegger CM, Owen LS, Davis PG. Nasal Intermittent Positive Pressure Ventilation for Neonatal 
Respiratory Distress Syndrome. Clin Perinatol. 2021 Dec; 48 (4): 725–744
7. Yoder BA, Manley B, Collins C, Ives K, Kugelman A, Lavizzari A, McQueen M. Consensus approach to 
nasal high-flow therapy in neonates. J Perinatol. 2017 Jul:37(7): 809-813
8. Committee on Fetus and Newborn; American Academy of Pediatrics. Respiratory support in preterm 
infants at birth. Pediatrics 2014; 133 Jan;133 (1) : 171–4.
9. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A, Plavka R, Roehr CC, Saugstad OD, Simeoni 
U, Speer CP , Vento M, Visser GHA, Halliday HL. European consensus guidelines on the management of 
respiratory distress syndrome – 2019 Update. Neonatology 2019; 115 (4): 432–450
10. Hodgson KA, Manley BJ, Davis PG. Is Nasal High Flow Inferior to Continuous Positive Airway Pressure for 
Neonates? Clin Perinatol. 2019 Sep;46(3): 537-55
11. Hodgson, K., Manley, B.J. (2022). Practical Applications of Nasal High-Flow Therapy. In: Donn, S.M., 
Mammel, M.C., van Kaam, A.H. (eds) Manual of Neonatal Respiratory Care. Springer, Cham. 
12. Lemyre, B., and Kirpalani H. “Noninvasive Ventilation: An Overview.” In: Donn, S.M., Mammel, M.C., van 
Kaam, A.H. (eds) Manual of Neonatal Respiratory Care. Springer, Cham. 
13. i Morley C. and Kirpalani H. Continuous Distending Pressure In: Donn, S.M., Mammel, M.C., van Kaam, 
A.H. (eds) Manual of Neonatal Respiratory Care. Springer, Cham

=== PAGE 801 ===

784 785
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 31: Asthma
1. Clinical Practice Guidelines for the Management of Childhood Asthma 2014. A Consensus Statement 
Prepared for the Academy of Medicine of Malaysia, Malaysian Thoracic Society and Lung Foundation of 
Malaysia.
2. 2022 GINA Report, Global Strategy for Asthma Management and Prevention. https://ginasthma.org/
gina-reports.
3. National Asthma Council Australia. Asthma Management Handbook 2020. Melbourne: National Asthma 
Council Australia. 2020. http://www.nationalasthma.org.au/   
4. BTS/SIGN British Guideline on the Management of Asthma 2019. http://www.sign.ac.uk   
5. Bradley E.Chipps et al. The Pediatric Asthma Yardstick. Ann Allergy Asthma Immunol 2018;120:559-579.
6. Timothy S.Chang et al. Evaluation of the Modified Asthma Predictive Index in High-Risk Preschool 
Children. J Allergy Clin Immunol Pract. 2013 Mar 1;1(2):10.1016/j.jaip.2012.10.008 
7. Paediatric Montelukast Study Group. Montelukast for Chronic Asthma in 6-14 year old children. JAMA 
April 1998.
8. Jenkins et al. Salmeterol/Fluticasone propionate combination therapy 50/250ug bd is more effective 
than budesonide 800ug bd in treating moderate to severe asthma. Resp Medicine 2000; 94: 715-723.
9. Liu LL, Gallaher MM, Davis RL, Rutter CM, Lewis TC, Marcuse EK. Use of a respiratory clinical score 
among different providers. Pediatr Pulmonol 2004;37(3):243-8.
10. Cynthia Szelc Kelly et al. Improved outcomes for hospitalized asthmatic children using a clinical pathway. 
Ann Allergy Asthma Immunol 2000;84:509-516.
11. Vézina K, Chauhan BF, Ducharme FM. Inhaled anticholinergics and short-acting beta-agonists versus 
short-acting beta2-agonists alone for children with acute asthma in hospital. Cochrane Database of 
Systematic Reviews 2014, Issue 7. Art. No.: CD010283. DOI: 10.1002/14651858.CD010283.pub2
12. Wyatt E, Borland M, Doyle S, Geelhoed G. Metered dose inhaler ipratropium bromide in moderate 
acute asthma in children: a single blinded randomised controlled trial. J. Paediatr. Child Health 2015; 51: 
192– 198. 
13. Colin VE P , Noel E C. The current role of ipratropium bromide in an acute exacerbation of asthma.  
Journal of Paediatrics and Child Health 51 (2015) 751–752.
14. Rowe BH, Spooner C, Ducharme F, Bretzlaff J, Bota G. Early emergency department treatment of acute 
asthma with systemic corticosteroids. Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No.: 
CD002178. DOI: 10.1002/14651858.CD002178
15. Horvath et al. Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma. Eur Respir 
J 2006; 27: 172–187
16. Edmonds ML, Milan SJ, Camargo Jr CA, Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the 
emergency department treatment of acute asthma. Cochrane Database of Systematic Reviews 2012, 
Issue 12. Art. No.: CD002308. DOI: 10.1002/14651858.CD002308.pub2SECTION 7: RESPIRATORY
Chapter 32: Acute Bronchiolitis
1. Kirolos A, Manti S, Blacow R, Tse G, Wilson T, Lister M, et al. A Systematic Review of Clinical Practice 
Guidelines for the Diagnosis and Management of Bronchiolitis. J Infect Dis. 2020;222(Suppl 7):S672–9.
2. Ng KF, Tan KK, Sam ZH, Ting GS and Gan WY: Epidemiology, clinical characteristics, laboratory findings 
and severity of respiratory syncytial virus acute lower respiratory infection in Malaysian children, 
2008-2013. J Paediatr Child Health 53:399-407, 2017.
3. Bronchiolitis in children: diagnosis and management. NICE guideline, published in 2015, updated in 
2021. https://www.nice.org.uk/Guidance/NG9 .
4. Jat KR, Dsouza JM, Mathew JL. Continuous positive airway pressure (CPAP) for acute bronchiolitis in 
children. Cochrane Database of Systematic Reviews 2022, Issue 4. Art. No.: CD010473. 

=== PAGE 802 ===

786
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 33: Viral Croup
Chapter 34: Pneumonia
Chapter 35: Empyema Thoracis in Children1. AG Kaditis, E R Wald: Viral croup; current diagnosis and treatment. Pediatric Infectious Disease Journal 
1998:7:827-34. 
2. Westley CR, Cotton EK, Brooks JG. Nebulized racemic epinephrine by IPPB for the treatment of croup: a 
double-blind study. Am J Dis Child 1978; 132:484
3. Toward Optimized Practice (TOP) Working Group for Croup. Guidelines for the diagnosis and 
management of croup (revised 2008). Available at www.topalbertadoctors.org/download/252/croup_
guideline.pdf (Accessed on March 13, 2015).
4. Clarke M, Allaire J. An evidence-based approach to the evaluation and treatment of croup in children. 
Pediatric Emergency Medicine Practice 2012; 9:1.
1. Von Mollendorf C, Berger D, Gwee A, Duke T, Graham SM, Russell FM, Mulholland EK; ARI review group. 
Aetiology of childhood pneumonia in low- and middle-income countries in the era of vaccination: a 
systematic review. J Glob Health. 2022 Jul 
2. Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community 
acquired pneumonia in children: Update 2011. Thorax 2011; 66:ii1
3. Bhuiyan, M.U., Blyth, C.C., West, R. et al. Combination of clinical symptoms and blood biomarkers can 
improve discrimination between bacterial or viral community-acquired pneumonia in children. BMC 
Pulm Med 19, 71 (2019)
4. Rishi Pabary, Ian M. Balfour-Lynn, Complicated Pneumonia in Children, Breathe 2013 9: 210-222; DOI: 
10.1183/20734735.043012
5. Yousif TI, Elnazir B. Approach to a child with recurrent pneumonia. Sudan J Paediatr 2015; 15(2):71 - 77
1. H. Hamm, RW Light, Pleural effusion and Parapneumonic effusion, Eur Respir J, 1997; 10: 1150–1156
2. Byington CL, Spencer LY , Johnson TA, Pavia AT, Allen D, Mason EO et al, An  epidemiological investigation 
of a sustained high rate of pediatric parapneumonic empyema:  risk factors and microbiological 
associations, Clin Infect Dis. 2002 Feb 15;34(4):434-40
3. Wexler ID, Knoll S, Picard E, Villa Y , Shoseyov D, Engelhard D et al, Clinical characteristics and outcome 
of complicated pneumococcal pneumonia in a pediatric population, Pediatr Pulmonol. 2006 Aug; 
41(8):726-34.
4. Lahti E, Peltola V, Virkki R, Alanen M, Ruuskanen O, Development of parapneumonic empyema in 
children, Acta Paediatr. 2007 Nov; 96(11):1686-92.
5. Picard E, Joseph L, Goldberg S, Mimouni FB, Deeb M, Kleid D et al, Predictive factors of morbidity in 
childhood parapneumonic effusion-associated pneumonia: a retrospective study, Pediatr Infect Dis J. 
2010 Sep;29(9):840-3.
6. Calder A, Owens CM, Imaging of parapneumonic pleural effusions and empyema in children, Pediatr 
Radiol. 2009 Jun; 39(6):527-37
7. Yang PC, Luh KT, Chang DB, Wu HD, Yu CJ, Kuo SH. Value of sonography in determining the nature of 
pleural effusions: analysis of 320 cases. Am J Roentgenol 1992; 159: 29–33
8. Pinotti KF, Ribeiro SM, Cataneo AJ, Thorax ultrasound in the management of pediatric pneumonias 
complicated with empyema, Pediatr Surg Int. 2006 Oct; 22(10):775-8.
9. Islam S, Calkins CM, Goldin AB, Chen C, Downard CD, Huang EY et al, Arca MJ, Abdullah F, St Peter SD; 
APSA Outcomes and Clinical Trials Committee, 2011-2012, The diagnosis and management  of empyema 
in children: a comprehensive  review from the APSA Outcomes  and Clinical Trials Committee,  Pediatr 
Surg. 2012 Nov; 47(11):2101-10.
10. May ML, Robson J, Microbiological diagnostic procedures in respiratory infections: suppurative lung 
disease, Paediatr Respir Rev. 2007 Sep;8(3):185-93

=== PAGE 803 ===

786 787
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCES11. Florian J. Segerer, Christine Hagemann, Andrea Streng, Karin Seeger, Christoph Schoen et al, Therapy of 
645 Children with Parapneumonic Effusion and Empyema —A German Nationwide Surveillance Study, 
Pediatr Pulmonology; 2017 (52):540–547
12. Zampoli M, Kappos A, Verwey C, Mamathuba R, Zar HJ. Impact of fibrinolytics on the outcome of 
empyema in South African children.  S Afr Med J. 2015 (21); 105(7): 549-53
13. Shirota C, Uchida H, Initial treatment of septated parapneumonic empyema with drainage plus 
fibrinolytic agents is equally effective as video assisted thoracoscopic surgery, and is suitable as first-line 
therapy, 10.3978/j.issn.2224-4336.2015.02.01
14. Ekingen G, Guvenc BH, Sozubir S, Tuzlacı A, Senel U, Fibrinolytic treatment of complicated pediatric 
thoracic empyemas with intrapleural streptokinase, Eur J Cardiothoracic Surg 2004 (26), 503–507
15. Sonappa S, Cohen G, Owens CM, van Doorn C, Cairns J, Stanojevic S et al, Comparison of Urokinase and 
Video-assisted Thoracoscopic surgery for treatment of Childhood Empyema, Am J Respir Crit Care Med. 
2006 (15);174(2):221-7.
16. Ozcelik   C, Inci I, Nizam O, Onat S, Intrapleural   Fibrinolytic   Treatment   of Multiloculated 
Postpneumonic Pediatric Empyemas, Ann Thorac Surg 2003;76:1849–53
17. Singh M, Mathew JL, Chandra S, et al. Randomized controlled trial of intrapleural streptokinase in 
empyema thoracis in children. Acta Paediatr 2004; 93: 1443-5.
18. HawkinsJ.A, Scaife E.S, Hillman N.D, Feola G.P , Current Treatment of Pediatric Empyema, Semin Thorac 
Cardiovasc Surg 2004;16:196-200
19. Thompson AH, Hull J, Kumar MR, et al. Randomised trial of intrapleural urokinase in the treatment of 
childhood empyema. Thorax 2002; 57:343-7.
20. Ben-Or S, Feins RH, Veeramachaneni NK, Haithcock BE. Effectiveness and risks associated with 
intrapleural alteplase by means of thoracostomy. Ann Thorac Surg 2011; 91:860 – 3
21. Blom D, van Alderaan VM, Alders JM.  Life threatening hemothorax following intrapleural administration 
of urokinase. Pediatr Pulmonol 2000; 20: 493.
22. Merry C.M, Bufo A.J, Shah R.S, Schropp K.P , Thorn E Lobe, Early Definitive Intervention by   
Thoracoscopy   in   Pediatric   Empyema, Pediatr   Surg, 1999;34:178-181.
23. Gates R.L, Caniano   D.A, Hayes J.R, Marjorie, Does VATS Provide Optimal Treatment of Empyema in 
Children? A Systematic Review, J Pediatr Surg 2004, 39(3):381-6
24. Bishay M, Short M, Shah K, Nagraj S, Arul S, Parikh D, Jawaheer G, Efficacy of video-assisted 
thoracoscopic surgery in managing childhood empyema:  a large single-centre study, J Pediatr Surg, 
2009;44: 337–342
25. Tan G.M, Goh A, Chay O.M, Subramaniam R, V.T. Joseph, Experience with Video- Assisted Thoracoscopic 
Surgery in the Management of Complicated Pneumonia in Children, J Pediatr Surg, 2001; 36 (2): 316-
319
26. Evan R. Kokoska, Mike K. Chen, Position paper on video-assisted thoracoscopic surgery as treatment of 
pediatric empyema, J Pediatr Surg (2009) 44, 289–293
27. Klena J.W, Cameron B.H, Langer JC, Winthrop A.L, Perez C.R, Timing of Video- Assisted Thoracoscopic 
Debridement for Pediatric Empyema, J Am Coll Surg 1998;187:404-408
28. B. A. Khalil, P . A. Corbett, M. O. Jones, T. Baillie, Southern K, P .D. Losty et al, Less is best? The impact of 
urokinase as the first line management of empyema thoracis, Pediatr Surg Int (2007) 23:129–133
29. Alexiou C, Goyal A, Firmin R.K, Hickey M.S, Is Open Thoracotomy Still a Good Treatment Option for the 
Management of Empyema in Children? Ann Thorac Surg 2003; 76: 1854 –8
30. Gates R.L, Hogan M, Weinstein S, Marjorie J, Drainage, Fibrinolytics, or Surgery: A Comparison of 
Treatment Options in Pediatric Empyema, Arca, J Pediatr   Surg 39:1638-1642.

=== PAGE 804 ===

788
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 36: Sleep Disordered Breathing
Chapter 37: Chronic Wet cough and Bronchiectasis1. Athanasios G. Kaditis, Maria Luz Alonso Alvarez, An Boudewyns, Emmanouel I. Alexopoulos, Refika Ersu, 
Koen Joosten, Helena Larramona, Silvia Miano, Indra Narang, Ha Trang, Marina Tsaoussoglou, Nele 
Vandenbussche, Maria Pia Villa, Dick Van Waardenburg, Silke Weber, Stijn Verhulst. Obstructive sleep 
disordered breathing in 2- to 18-year-old children: diagnosis and management. European Respiratory 
Journal 2016 47: 69-94 
2. Carole L. Marcus, Lee Jay Brooks, Kari A. Draper, David Gozal, Ann Carol Halbower, Jacqueline Jones, 
Michael S. Schechter, Stephen Howard Sheldon, Karen Spruyt, Sally Davidson Ward, Christopher 
Lehmann, Richard N. Shiffman. Clinical Practice Guidelines : Diagnosis and Management of Childhood 
Obstructive Sleep Apnea Syndrome. PEDIATRICS Volume 130, Number 3, September 2012
3. Gillian M Nixon, Margot J Davey. Sleep apnoea in the child. AFP VOL.44, NO.6, JUNE 2015
4. https://starship.org.nz/guidelines/obstructive-sleep-apnoea/
5. Clinical Practice Guidelines : Management of Obstructive Sleep Apnoea (Ministry of Health Malaysia, 
2022) 
6. Chervin RD, Hedger K, Dillon JE, et al. Pediatric sleep questionnaire (PSQ) : Validity and reliability of 
scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med. 
2000:1;1(1):21-32
7. Hasniah AL, Jamalludin AR, Norrashidah AW, et al. Cross-cultural adaptation and reliability of pediatric 
sleep questionnaire in assessment of sleep-disordered breathing in the Malay speaking population. 
World J Pediatr. 2012;8(1):38-42
1. Wurzel DF, Marchant JM, Yerkovich ST, Upham JW, Petsky HL, Smith-Vaughan H, Masters B, Buntain 
H, Chang AB. Protracted Bacterial Bronchitis in Children: Natural History and Risk Factors for 
Bronchiectasis. Chest. 2016 Nov;150(5):1101-1108. doi: 10.1016/j.chest.2016.06.030. Epub 2016 Aug 
24. PMID: 27400908. 
2. Peter Pohunek, Tamara Svobodova. Bacterial Bronchitis with Chronic Wet Cough in ERS Handbook: 
Paediatric Respiratory Medicine, 1st edition 2013, p266-269.
3. Chang AB, Andrew B, Grimwood K. Bronchiectasis in children: diagnosis and treatment. The 
Lancet,2018, Vol. 392, No. 10150; 866
4. Elif Dagli. Non-CF Bronchiectasis in ERS Handbook: Paediatric Respiratory Medicine, 1st edition 2013, 
p253-257
5. Chang AB, Fortescue R, Grimwood K, et al. Task Force report: European Respiratory Society guidelines 
for the management of children and adolescents with bronchiectasis. Eur Respir J 2021; in press 
(https://doi.org/10.1183/13993003.02990-2020).
6. Chang AB, Grimwood K, Boyd J, et al. Management of children and adolescents with bronchiectasis: 
summary of the ERS clinical practice guideline. Breathe 2021; 17:210105.

=== PAGE 805 ===

788 789
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 38: Paediatric Electrocardiography (ECG)
Chapter 40: Hypercyanotic spell
Chapter 41: Heart FailureChapter 39: Critical Congenital Heart Disease
Chapter 42: Rheumatic Heart Disease1. Dickinson DF. The normal ECG in childhood and adolescence. Heart 2005 Dec;91(12):1626-30
2. Mikrou P , Shivaram P , Kanaris C. How to interpret the paediatric 12-lead ECG. Arch Dis Child Educ Pract 
Ed 2022 Aug;107(4):279-287 
3. Goodacre S, McLeod K. ABC of clinical electrocardiography: Paediatric electrocardiography. BMJ 2002 
Jun 8;324(7350):1382-5
1. Medical management of hypercyanotic spells in neonates, infants with Tetralogy of Fallot. Paediatric 
Innovation, Education and Research Network
2. Management of a hypercyanotic spell (Tetralogy of Fallot): e-Clinical Guidelines Template, Leeds 
Teaching Hospitals Trust
1. Masarone D, Valente F, Rubino M, Vastarella R, Gravino R, Rea A, Russo MG, Pacileo G, Limongelli G. 
Pediatric Heart Failure: A Practical Guide to Diagnosis and Management. Pediatr Neonatol. 2017 
Aug;58(4):303-3121. Shaddy RE, Penny D, Feltes TF, et al. Moss & Adams’ Heart Disease in Infants, Children, Adolescents, 
Including the Fetus and Young Adult, 10th edition. Lippincott Williams & Wilkins (LWW), 2021
2. Mahle WT, Newburger JW, Matherne GP , Smith FC, Hoke TR, Koppel R, et al. Role of pulse oximetry 
in examining newborns for congenital heart disease. A scientific statement from the American Heart 
Association and American Academy of Pediatrics. Circulation. 2009;120(5):447–58. 
3. Oster M, Lee K, Honein M, Colarusso T, Shin M, Correa A. Temporal trends in survival for infants with 
critical congenital heart defects. Pediatrics. 2013;131(5):e1502-8.
4. Prostin BR Pediatric ® Alprostadil Injection product leaflet. Revised October 2008
5. Shann F. Drug Doses. 17th ed. Victoria, Royal Children’s Hospital; 2017
6. Lexi-Comp, Inc. (Pediatric & Neonatal Lexi-Drugs). Lexi-Comp, Inc (Version 3.0.2)
1. Ralph AP , Noonan S, Wade V, Currie BJ. The 2020 Australian guideline for prevention, diagnosis and 
management of acute rheumatic fever and rheumatic heart disease. Medical Journal of Australia  2020, 
214(5), 220–227. 
2. Heart Foundation of New Zealand. New Zealand Guidelines for Rheumatic Fever: Diagnosis, 
Management and Secondary PRevention of Acute Rheumatic Fever and Rheumatic Disease: 2014 
Update.
3. Otto CM, Nishimura RA, Bonow RO et al. 2020 ACC/AHA guideline for the management of patients with 
valvular heart disease: A report of the American College of Cardiology/American Heart Association joint 
committee on clinical practice guidelines. Circulation  2021, 143(5). 
4. Vahanian A, Beyersdorf F, Praz F et al. 2021 ESC/EACTS Guidelines for the management of Valvular Heart 
Disease. European Heart Journal 2021, 43(7), 561–632. SECTION 8: CARDIOLOGY

=== PAGE 806 ===

790
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 43: Infective Endocarditis
Chapter 44: Kawasaki Disease
Chapter 45: Paediatric Arrhythmias 1. European Cardiac Society Guidelines for the management of infective endocarditis 2015
2. Clinical Practice Guidelines for the Prevention, Diagnosis & Management of Infective Endocarditis 2017
1. McCrindle BW, Rowley AH, Newburger JW et al. Diagnosis, treatment, and long-term management of 
Kawasaki disease: a scientific statement for health professionals from the American Heart Association. 
Circulation. 2017;135:e927–99
2. Kobayashi T, Ayusawa M, Suzuki H et al. Revision of diagnostic guidelines for Kawasaki disease (6th 
revised edition) Pediatr Int. 2020;62:1135–8
3. Fukazawa R, Kobayashi J, Ayusawa M et al. JCS/JSCS 2020 guideline on diagnosis and management of 
cardiovascular sequelae in Kawasaki disease. Circ J. 2020;84:1348–407
1. Dresing TJ, L Wilkoff B. Bradyarrhythmias. Curr Treat Options Cardiovasc Med 2001;3:291-298
2. Mangrum JM, DiMarco JP . The evaluation and management of bradycardia. N Engl J Med 2000;342:703–9
3. Baruteau AE, Perry JC, Sanatani S, Horie M, Dubin AM. Evaluation and management of bradycardia in 
neonates and children. Eur J Pediatr 2016;175:151-61
4. Concise Guide to Paediatric Arrythmias. Christopher Wren. First published 2012 © 2012 by John Wiley 
&amp; Sons Ltd
5. Epstein AE, DiMarco JP , Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy 
of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart 
Association Task Force on Practice Guidelines. Circulation 2008;117:e350-408.
6. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task 
Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology 
(ESC) with the special contribution of the European Heart Rhythm Association (EHRA). Eur Heart J 
2021;42:3427-3520

=== PAGE 807 ===

790 791
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 46: Neonatal Seizures
Chapter 48: EpilepsyChapter 47: Status Epilepticus1. Volpe JJ. Neurology of the newborn. 5th Edition. Elsevier 2008.
2. Van Hove JL, Lohr NJ. Metabolic and monogenic causes of seizures in neonates and young infants. 
Molecular genetics and metabolism. 2011;104(3):214-230.
3. Glass HC, Wusthoff CJ, Shellhaas RA, et al. Risk factors for EEG seizures in neonates treated with 
hypothermia: a multicenter cohort study. Neurology. 2014;82(14):1239-1244.
4. Cross JH. Differential diagnosis of epileptic seizures in infancy including the neonatal period. Seminars in 
fetal & neonatal medicine. 2013;18(4):192-195.
5. Slaughter LA, Patel AD, Slaughter JL. Pharmacological treatment of neonatal seizures: a systematic 
review. Journal of child neurology. 2013;28(3):351-364.
6. Glass HC, Poulin C, Shevell MI. Topiramate for the treatment of neonatal seizures. Pediatric neurology. 
2011;44(6):439-442.
7. Hellström-Westas, de Vries, Rosen, Atlas of Amplitude-Integrated EEGs in the Newborn, 2nd edition
8. van Rooij LG, Hellstrom-Westas L, de Vries LS. Treatment of neonatal seizures. Seminars in fetal & 
neonatal medicine. 2013;18(4):209-215.
9. Garfinkle J, Shevell MI. Prognostic factors and development of a scoring system for outcome of neonatal 
seizures in term infants. European journal of paediatric neurology. EJPN 2011;15(3):222-229.
1. Smith SJM. EEG in the diagnosis, classification and management of patients with epilepsy. J Neurol 
Neurosurg Psych 2005; 76(Suppl II): ii2-ii7
2. Baumer JH. Evidence based guideline for post-seizure management in children presenting acutely to 
secondary care. Arch Dis Child 2004;89:278-80
3. International League Against Epilepsy (ILAE) website: www.ilae.org
4. Operational classification of seizure types by the International League Against Epilepsy: Position Paper 
of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58(4):522-530. 
5. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and 
Terminology. 2017; 58(4):512-521.
6. Methodology for Classification and Definition of Epilepsy Syndromes with List of Syndromes 2022. 
Epilepsia. 2022;63:1333–1348
7. National Institute for Health and Care Excellence (NICE): Epilepsies: Epilepsies in Children, Young People 
and Adults (April 2022)
8. UpToDate1. Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus - Report of the 
ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015; 56:1515-23.
2. Review of the new APLS guideline (2021): Management of the Convulsing Child.
3. Eugen Trinka. Pharmacotherapy for Status Epilepticus. 2015;75:1499–1521.
4. Glauser T, Shinnar S, Gloss D, et al. Evidence-Based Guideline: Treatment of Convulsive Status 
Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.  
Epilepsy Curr. 2016; 16(1):48-61. Section 9: Neurology

=== PAGE 808 ===

792
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 49: Febrile Seizures
Chapter 50: Meningitis1. Neurodiagnostic evaluation of the child with a simple febrile seizure. Sub- committee of febrile seizure; 
American Academy of Pediatrics. Pediatrics 2011;127(2):389-94
2. Shinnar S. Glauser T. Febrile seizures. J Child Neurol 2002; 17: S44-S52
3. Eilbert W, Chan C. Febrile seizures: A review. J Am Coll Emerg Physicians Open 2022 Aug 23;3(4):e12769.
1. Alamarat Z, Hasbun R. Management of acute bacterial meningitis in children. Infect Drug Resist. 
2020;13(11):4077–4089.
2. Bahr NC, Marais S, Caws M et al. Tuberculous Meningitis International Research Consortium. GeneXpert 
MTB/Rif to Diagnose Tuberculous Meningitis: Perhaps the First Test but not the Last. Clin Infect Dis. 
2016; 62(9):1133-5.
3. Tian C, Jin S, Zhao Z, et al. Association of corticosteroid treatment with outcomes in pediatric patients 
with bacterial meningitis: a systematic review and meta-analysis of randomized controlled trials. Clin 
Ther. 2022;44:551–64.
4. National Antimicrobial Guidelines 2019. Ministry of Health, Malaysia.
Chapter 51: Autoimmune Encephalitis
Chapter 52: Status Dystonicus
Chapter 53: Acute Demyelinating Syndromes1. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet 
Neurol. 2016; 15(4):391-404. 
2. Mark A Ellul et al. Update on the diagnosis and management of autoimmune encephalitis. Clin Med 
(Lond). 2020; 20(4): 389–392.
3. Hesham Abboud. Autoimmune encephalitis: proposed best practice recommendations for diagnosis 
and acute management. J Neurol Neurosurg Psychiatry 2021; 92:757–768
4. Alessandro et al. Treatment Options in Refractory Autoimmune Encephalitis. CNS Drugs. 2022;36:919–
931
1. Allen NM, Lin JP , Lynch T, King MD. Status dystonicus: a practice guide. Dev Med Child Neurol. 2014; 
56(2):105-12. 
2. Clinical guideline. Dystonia identification, investigations and management in children. Bristol Royal 
Hospital For Children.
3. Lumsden D. The Child With Dystonia. Paediatrics and Child Health 2018; 28(10): 459-467
1. Pediatric Multiple Sclerosis and Demyelinating Disorders: Global Update and Future Directions 
(Supplement 2). Neurology August 30, 2016;87(9 Supplement 2) https://neurology.org/content/87/9_
Supplement_2
2. E.U. Paediatric MOG consortium consensus. European Journal of Peadiatric Neurology (2020)

=== PAGE 809 ===

792 793
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
Chapter 54: Acute Flaccid Paralysis
Chapter 55: The Child with Altered Consciousness
Chapter 56: Childhood Stroke
Chapter 57: Infection Related Encephalopathy in Childhood1. Global Polio Eradication Initiative . http://www.polioeradication.org/, Unit Virologi, Institute for Medical 
Research, Malaysia
2. Murphy OC, Messacar K, Benson L, Bove R, Carpenter JL, Crawford T, et al. Acute flaccid myelitis: cause, 
diagnosis, and management. Lancet. 2021;397(10271):334-46.
3. Korinthenberg R, Trollmann R, Felderhoff-Müser U, et al. Diagnosis and treatment of Guillain-Barré 
Syndrome in childhood and adolescence: An evidence- and consensus-based guideline. Eur J Paediatr 
Neurol. 2020;25:5-16
1. Management of children and young people with an acute decrease in conscious level. 2015 Update, 
RCPCH. http://www.rcpch.ac.uk/improving-child-health/clinical-guidelines-and-standards/published-
rcpch/management-children-and-you
2.  Introducing the Guideline on the Management of a Child with a decreased Conscious Level: A 
Nationally Developed Evidence-based Guideline for Hospital Practitioners (The Paediatric Accident and  
Emergency Research Group, The University of Nottingham) KC Chan et al. HK J Paediatr (new series) 
2013;18:105-116. 
3. Infants and children: Acute Management of Altered Consciousness in Emergency Departments: 
First Edition, Clinical Practice Guideline Departments: First Edition, NSW Clinical Practice Guideline 
(Published 15 Dec 2014, revision 15 Dec 2019). http://www.health.nsw.gov.au/policies
1. Ferriero DM, Fullerton HJ, Bernard TJ, et al; on behalf of the American Heart Association Stroke Council 
and Council on Cardiovascular and Stroke Nursing. Management of stroke in neonates and children: 
a scientific statement from the American Heart Association / American Stroke Association. Stroke. 
2019;50(3):e51-e96. 
2. Vijeya Ganesan, et al. Stroke in childhood: Clinical guideline for diagnosis, management and 
rehabilitation. RCPCH; May 2017. 
3. Mario Mastrangelo, Laura Giordo, Giacomina Ricciardi, et al. Acute ischemic stroke in childhood: a 
comprehensive review. European Journal of Pediatrics 2022;(181):45–58.
4. Milena Jankovic, Bojana Petrovic, Ivana Novakovic , et al. The genetic basis of strokes in pediatric 
populations and insight into new therapeutic options. Int. J, Mol. Sci. 2022;23:1601. 
1. Hoshino, A. et al. Epidemiology of acute encephalopathy in Japan, with emphasis on the association of 
viruses and syndromes. Brain Dev. 2012; 34(5): 337-343.
2. Mizuguchi, M. et al. Guidelines for the diagnosis and treatment of acute encephalopathy in childhood. 
Brain Dev 2021;43(1): 2-31.
3. Kaur P . et al. Fever, Seizures and Encephalopathy: From Bush Fires to Firestorms. Ann Indian Acad 
Neurol 2022;25(4): 587-600.                        REFERENCES

=== PAGE 810 ===

794
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 58: Approach to Short Stature 
Chapter 59: Congenital Hypothyroidism 
Chapter 60: Diabetes Mellitus
Chapter 61: Diabetic Ketoacidosis and Hyperglycaemic Hyperosmolar State1. Grimberg A, De Leon DD. Chapter 8: Disorders of growth. In: Pediatric Endocrinology, the Requisites in 
Pediatrics 2005, pp127-167. 
2. Cutfield WS, et al. Growth hormone treatment to final height in idiopathic GH deficiency: The KIGS 
Experience, in GH therapy in Pediatrics, 20 years of KIGS, Basel, Karger, 2007. pp 145-62. 
3. Molitch ME, et al. Evaluation and treatment of adult GH deficiency: An Endo crine Society Clinical 
Practice Guideline. JCEM 1991; 19: 1621-1634, 2006. 
4. Malaysian Clinical Practice Guidelines on usage of growth hormone in children and adults 2011)
5. Barstow C, Rerucha C. Evaluation of Short and Tall Stature in Children. Am Fam Physician. 
2015;92(1):43–50. 
6. Rogol AD, Hayden GF. Etiologies and early diagnosis of short stature and growth failure in children and 
adolescents. J Pediatr. 2014;164(5 suppl): S1-S14.
1. Wu Loo Ling, Arini Nuran Md Idris, Azriyanti Anuar Zaini, Fuziah Md Zain, Hong Soo Synn Joyce, Hong 
Yeow Hua Janet, Lee Yee Lin, Lim Poi Giok, Lim Song Hai, Muhammad  Yazid Jalaludin, Nalini M. 
Selveindran, Noor Shafina Mohd Nor, Rahmah Rasat, Rashdan Zaki Mohamed, Sze Lyn Jeanne Wong. 
Consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism in 
Malaysia. 2021. 
2. Maynika V Rastogi, Stephen H LaFranchi. Congenital hypothyroidism. Orphanet Journal of Rare Disease 
2010, 5: 17; http://www.ojrd.com/content/5/1/17 
3. Paul van Trotsenburg, Athanasia Stoupa, Juliane Leger et al. Congenital Hypothyroidism: A 2020-2021 
Consensus Guidelines Update – An ENDO-European Reference Network Initiative Endorsed by the 
European Society for Pediatric Endocrinology and the European Society for Endocrinology. Thyroid 
March 2021. 387-419. 
4. Keisuke Nagasaki, Kanshi Minamitani, Makoto Anzo et al. Guidelines for Mass Screening of Congenital 
Hypothyroidism (2014 revision) Clin Pediatr Endocrinol 2015;24 (3), 107-133. 
1. International Society for Pediatric and Adolescent Diabetes (ISPAD) Clinical Practice Consensus 
Guidelines 2022. 
1. International Society for Pediatric and Adolescent Diabetes (ISPAD) Clinical Practice Consensus 
Guidelines 2022. Section 10: Endocrinology

=== PAGE 811 ===

794 795
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 64: Acute Glomerulonephritis  
Chapter 65: Nephrotic Syndrome1. Ozen S, Marks SD, Brogan P et al. European consensus-based recommendations for diagnosis and 
treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford). 2019 Sep 
1;58(9):1607-1616
2. John R. Sedor, Chapter 14 - Acute glomerulonephritis and rapidly progressive glomerulonephritis, 
Editor(s): Edgar V. Lerma, Matthew A. Sparks, Joel M. Topf, Nephrology Secrets (Fourth Edition), Elsevier, 
2019, 99-104 
3. Abdul Rahman AR, Rosman A, Chia YC et al. Clinical Practice Guidelines Management of Hypertension. 
5th Edition 2018. Ministry of Health Malaysia
4. Kidney Disease Improving Global Outcomes. KDIGO 2021 Clinical practice guideline for the management 
of glomerular diseases. Kidney Int 2021; 100 (4S): S1–S276. 
1. Sinha A, Bagga A, Banerjee S et al. Expert Group of Indian Society of Pediatric Nephrology. Steroid 
Sensitive Nephrotic Syndrome: Revised Guidelines. Indian Pediatr 2021 May 15;58(5):461-481
2. Rovin BH, Adler SG, Barratt J et al.  KDIGO 2021 clinical practice guideline for the management of 
glomerular diseases. Kidney int 2021 100(4):S1-S276
3. Abeyagunawardena AS, Trompeter RS. Increasing the dose of prednisolone during viral infections 
reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial. Arch Dis Child. 2008 
Mar;93(3):226-8
4. Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV et al. Short courses of daily prednisolone 
during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome. 
Pediatr Nephrol 2017 Aug;32(8):1377-1382
5. Trautmann A, Vivarelli M, Samuel S et al. IPNA clinical practice recommendations for the diagnosis 
and management of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 2020 
Aug;35(8):1529-1561
6. Trautmann A, Boyer O, Hodson Ee t al. IPNA clinical practice recommendations for the diagnosis 
and management of children with steroid sensitive nephrotic syndrome. Paediatr Nephrol 2023 
Mar;38(3):877-919
7. Abu Bakar K, Khalil K, Lim YN et al. Adrenal Insufficiency in Children With Nephrotic Syndrome on 
Corticosteroid Treatment. Front Pediatr. 2020 Apr 15;8:164.
8. Vaccine Recommendations and Guidelines of the ACIP Altered Immunocompetence Update August 
2023Section 11: Nephrology
Chapter 66: Acute Kidney Injury
1. Liu KD, Goldstein SL, Vijayan A, et al. AKI Now Initiative: Recommendations for Awareness, Recognition, 
and Management of AKI. Clin J Am Soc Nephrol 2020; 15(12):1838-1847
2. Marzuillo P , Baldascino M, Guarino S et al. Acute kidney injury in children hospitalized for acute 
gastroenteritis: prevalence and risk factors. Pediatr Nephrol. 2021;36(6):1627-1635
3. Fahimi D, Mohajeri S, Hajizadeh N et al. Comparison between fractional excretions of urea and sodium 
in children with acute kidney injury. Pediatr Nephrol. 2009;24(12):2409-12
4. Charlton JR, Boohaker L, Askenazi D et al. Neonatal Kidney Collaborative. Incidence and Risk Factors of 
Early Onset Neonatal AKI. Clin J Am Soc Nephrol. 2019 Feb 7;14(2):184-195
5. Schwartz GJ, Brion LP , Spitzer A. The use of plasma creatinine concentration for estimating glomerular 
filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987;34(3):571-90

=== PAGE 812 ===

796
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 67: Acute Dialysis
Chapter 68: Neurogenic Bladder1. Paediatric Nephrology 5th edition, editors Ellis D Avner, William E Harmon, Patrick Niaudet, Lippincott  
Williams & Wilkins, 2004
2. Renal Replacement Therapy Clinical Practice Guidelines (4th Edition 2017) Ministry of Health, Malaysia
3. Li PK, Chow KM, Cho Y et al. ISPD peritonitis guideline recommendations: 2022 update on prevention 
and treatment. Perit Dial Int. 2022 Mar;42(2):110-153
4. Nourse P , Cullis B, Finkelstein F, et al. ISPD guidelines for peritoneal dialysis in AKI: 2020 Update 
(pediatrics). Perit Dial Int. 2021 Mar; 41(2):139-157
5. Raajimakers R, Schrὄder CH, Gajjar P , et al. CFPD: First experience in children with acute renal failure. 
Clin J Am Soc Nephrol 2011, 6: 311-318
6. Yap HK, Teo S, Ng KH. Pediatric Nephrology On-The-Go (4th edition 2021)    
7. Raina R, Grewal MK, Blackford M et al. Renal replacement therapy in the management of intoxications 
in children: recommendations from the PCRRT workgroup. Pediatr Nephrol (2019) 34: 2427-2448
1. European Association of Urology. Guidelines on Neurogenic Lower Urinary Tract Dysfunction 2008.
2. European Association of Urology. Guidelines on Paediatric Urology 2022
3. Verpoorten C, Buyse GM. The neurogenic bladder: medical treatment. Pediatr Nephrol 2008;23(5):717-
725
4. Teaching an supporting clean intermittent catheterization for parents and children. Nursing clinical 
guidelines. The Royal Children’s Hospital Melbourne. 2019 June
5. Boo NY , Cheah IGS, Thong MK et al. Neural tube defects in Malaysia: Data from the Malaysian National 
Neonatal Registry. J Trop Ped 2013 Oct;59(5):338-342
6. Dik P , Klijn AJ, van Gool JD et al. Early start to therapy preserves kidney function in spina bifida patients. 
Eur Urol 2006;49(5):908-13
7. Baka-Ostrowska M, Bolong DT, Persu C et al. Efficacy and safety of mirabegon in chidren and 
adolescents with neurogenic detrusor overactivity: An open-label, phase 3, dose-titration study. 
Neurourol Urodyn 2021;40(6):1490-99
8. B Lee, N Featherstone, P Nagappan et al. British Association of Pediatric Urologists consensus statement 
on the management of the neuropathic bladder. J Pediatr Urol 2016 Apr;12(2):76-87
9. Seki N, Masuda K, Kinukawa N et al. Risk factors for febrile urinary tracrt infection in children with 
myelodysplasia treated by clean intermittent catheterizatrion. Int J Urol 2004 Nov;11:973-7
10. Figueroa V, Ramao R, Pippi Salle JL et al. Single-center experience with botulinium toxin endoscopic 
detrusor injection for the treatment of congenital neuropathic bladder in children. J Pediatr Urol 2014 
Apr;10(2):368-373
11. Nguyen MT, Pavlock CL, Zderic SA et al. Overnight catheter drainage in children with poorly compliant 
bladders improves post- obstructive diuresis and urinary incontinence J Urol 2005 Oct;174(4 Pt 2):1633-
6

=== PAGE 813 ===

796 797
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 69: Urinary Tract Infection
Chapter 70: Perinatal Urinary Dilatation1. National Institute for Health and Clinical Excellence Urinary tract infection in children: diagnosis, 
treatment and long-term management. October 2018
2. Garin EH, Olavarria F, Nieto VG et al. Clinical significance of primary VUR and urinary antibiotic 
prophylaxis after acute pyelonephritis: a multicenter randomized controlled study. Pediatrics 
2006;117;626-632
3. Williams GJ, Wei L, Lee A et al. Long term antibiotics for preventing recurrent urinary tract infection in 
children. Cochrane Database of Systematic Review 2006, Issue 3
4. Michael M, Hodson EM, Craig JC et al. A Short versus standard duration oral antibiotic therapy for acute 
UTI in children. Cochrane Database of Systematic Reviews 2006 Issue 3.
5. Bloomfield P , Hodson EM and Craig JC. Antibiotics for acute pyelonephritis in children. The Cochrane 
Database of Systematic Reviews 2007 Issue 1.
6. Hodson EM, Wheeler DM, Nimalchandra et al. Interventions for primary vesicoureteric reflux (VUR). 
Cochrane Database of Systematic Reviews 2007 Issue 3.
7. American Academy of Pediatrics. Technical report- Diagnosis and Management of an Initial UTI in 
Febrile Infants and Young Children. Pediatrics Volume 128, Number 3, September 2011
8. Brandstrom P , Esbjorner E, Herthelius M et al. The Swedish Reflux Trial in Children,  part III: urinary tract 
infection pattern. J Urol. 2010;184(1):286-291
9. Stein R, Dogan HS, Hoebeke P et al. European Association of Urology; European Society for Pediatric 
Urology. Urinary tract infections in children: EAU/ESPU guidelines. Eur Urol. 2015 Mar;67(3):546-58.
10. Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment 
of chronic constipation of childhood. Pediatrics 1997; 100:2 
1. Nguyen HT, Phelps A, B Coley B et al. 2021 update on the urinary tract dilation (UTD) classification 
system: clarifications, review of the literature, and practical suggestions. Pediatr Radiol 2022 
Apr;52(4):740-75
2. Sidhu G, Beyene J, Rosenblum ND. Outcome of isolated antenatal hydronephrosis: a systematic review 
and meta-analysis. Pediatr Nephrol 2006 Feb;21(2):218-224 
3. Lee RS, Cendron M, Kinnamon DD et al. Antenatal hydronephrosis as a predictor of postnatal outcome: 
a meta-analysis Pediatrics 2006 Aug;118(2):586-593
4. Kalra S, Dey SK, Shankar R et al. Antibiotic prophylaxis for VCUG: a cross-sectional observational study. 
Indian J Pediatr 2020 Mar;87(3):238
5. Braga LH, Mijovic H, Farrokhyar F et al. Antibiotic prophylaxis for urinary tract infections in antenatal 
hydronephrosis. Pediatrics 2013 Jan;131(1):e251-61

=== PAGE 814 ===

798
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 71: Hypertension (HTN) in Children
Chapter 72: Chronic Kidney Disease (CKD) in Children1. Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management 
of High Blood Pressure in Children and Adolescents. Pediatrics. 2017; 140(3): e20171904  
2. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and 
Adolescents. The Fourth Report on The Diagnosis, Evaluation, and Treatment of High Blood Pressure in 
Children and Adolescents. Pediatrics. 2004; 114:555
3. Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al. 2016 European Society of Hypertension Guidelines for 
the Management of High Blood Pressure in Children and Adolescents. Hypertension. 2016; 34:1887
4. Flynn JT, Tullus K. Severe Hypertension in Children and Adolescents: Pathophysiology and Treatment. 
Pediatr Nephrol 2009; 24:1101
5. Flynn JT, Urbina EM, Brady TM, et al. Ambulatory Blood Pressure Monitoring in Children and 
Adolescents: 2022 Update: A Scientific Statement From the American Heart Association. Hypertension. 
2022; 79:e114-e124 
6. AAP Pediatric Hypertension Guidelines -MDCalc   https://www.mdcalc.com/calc/4052/aap-pediatric-
hypertension-guidelines
1. Gomez RA, Sequeira Lopez ML, Fernandez L et al.  The Maturing Kidney: Development and 
Susceptibility. Ren Failure 1999;21(3-4): 283-291
2. Smeets NJL, IntHout J, van der Burgh MJP et al. Maturation of GFR in Term-Born Neonates: An Individual 
Participant Data Meta-Analysis. J Am Soc Nephrol 2022;33 (7):1277-1292 
3. ESCAPE Trial Group; Wuhl E, Trivelli A, Picca S et al. Strict blood-pressure control and progression of 
renal failure in children. N Engl J Med 2009;361(17):1639–1650
4. Staples AO, Greenbaum LA, Smith JM, et al. Association between clinical risk factors and progression of 
chronic kidney disease in children. Clin J Am Soc Nephrol. 2010;5(12):2172-2179 
5. Kamath N, Iyengar A, George N et al. Risk Factors and Rate of Progression of CKD in Children. Kidney Int 
Rep. 2019;4(10):1472-1477. 
6. Schwartz GJ, Muñoz A, Schneider MF et al. New equations to estimate GFR in children with CKD. J Am 
Soc Nephrol. 2009 Mar;20(3):629-637. 
7. Pottel H, Mottaghy FM, Zaman Z et al. On the relationship between glomerular filtration rate and serum 
creatinine in children. Pediatr Nephrol. 2010 May;25(5):927-934
8. Klaus G, Watson A, Edefonti A et al. Prevention and treatment of renal osteodystrophy in children on 
chronic renal failure: European guidelines. Pediatr Nephrol. 2006 Feb;21(2):151-9 
9. Shroff R, Wan M, Nagler EV.Clinical practice recommendations for native vitamin D therapy in children 
with chronic kidney disease Stages 2-5 and on dialysis. Nephrol Dial Transplant 2017;32(7):1098-1113
10. Shroff R, Wan M, Nagler EV et al. Clinical practice recommendations for treatment with active vitamin 
D analogues in children with chronic kidney disease Stages 2-5 and on dialysis. Nephrol Dial Transplant. 
2017;32(7):1114-1127 
11. 11. Shaw V, Polderman N, Renken-Terhaerdt, J et al. Energy and protein requirements for children with 
CKD stages 2-5 and on dialysis–clinical practice recommendations from the Pediatric Renal Nutrition 
Taskforce. Pediatr Nephrol 2020;35(3):519–531 

=== PAGE 815 ===

798 799
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 73: Congenital anomalies kidney and urinary tract (CAKUT)
1. Egbe A, Uppu S, Lee S, et al. Congenital malformations in the newborn population: A population study 
and analysis of the effect of sex and prematurity. Pediatr Neonatol 2015 56(1):25-30.
2. Stoll C, Dott B, Alembik Y , Roth MP . Associated nonurinary congenital anomalies among infants with 
congenital anomalies of the kidney and urinary tract (CAKUT). Eur J Med Genet 2014;57(7):322-328.
3. Goodyer P , Kurpad A, Rekha S et al. Effects of maternal vitamin A status on kidney development: A pilot 
study. Pediatr Nephrol 2007;22(2):209–214 
4. Hayes WN, Watson AR, Trent and Anglia MCDK Study Group. Unilateral multicystic dysplastic kidney: 
Does initial size matter? Pediatr Nephrol 2012 27(8):1335-40
5. Kohl S, Avni FE, Boor P et al. Definition, diagnosis and clinical management of non-obstructive kidney 
dysplasia: a consensus statement by the ERKNet Working Group on Kidney Malformations Nephrol Dial 
Transplant 2022;37(2):2351-62  

=== PAGE 816 ===

800
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 74: Approach to a Child with Anemia  
Chapter 75: Thalassemia  
Chapter 76: Immune Thrombocytopenia  
Chapter 77: Haemophilia  
Chapter 78 & 79: Oncologic Emergencies and Acute Lymphoblastic Leukaemia1. Ozen S, Marks SD, Brogan P et al. European consensus-based recommendations for diagnosis and 
treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford). 2019 Sep 
1;58(9):1607-1616
2. John R. Sedor, Chapter 14 - Acute glomerulonephritis and rapidly progressive glomerulonephritis, 
Editor(s): Edgar V. Lerma, Matthew A. Sparks, Joel M. Topf, Nephrology Secrets (Fourth Edition), Elsevier, 
2019, 99-104 
3. Abdul Rahman AR, Rosman A, Chia YC et al. Clinical Practice Guidelines Management of Hypertension. 
5th Edition 2018. Ministry of Health Malaysia
4. Kidney Disease Improving Global Outcomes. KDIGO 2021 Clinical practice guideline for the management 
of glomerular diseases. Kidney Int 2021; 100 (4S): S1–S276. 
1. 2021 Guidelines for the Management of Transfusion-dependent Thalassemia, Thalassaemia 
International Federation, 4th Edition
1. George J, et al. (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit 
methods for the American Society of Hematology. Blood 1996; 88: 3-40.
2. Lilleyman J. Management of Childhood Idiopathic Thrombocytopenic Purpura. Brit J Haematol 1997; 
105: 871-875
3. James J. Treatment Dilemma in Childhood Idiopathic Thrombocytopenic Purpura. Lancet 305: 602
4. Nathan D, Orkin S, Ginsburg D, Look A. Nathan and Oski’s Hematology of Infancy and Childhood. 6th ed 
2003. W.B. Saunders Company.
5. IWG (International Working Group) Proposal on Classification of ITP . Blood 2009;113:2386-2393
1. Clinical Practice Guideline on Management of Haemophilia, Ministry of Health Malaysia 2018, MOH/P/
PAK/412.18/(GU)-e
2. WFH Guidelines on the Management of Haemophilia, World Federation of Haemophilia, 3rd Edition, 
2020.
1. Pizzo, Poplack: Principles and Practice of Paediatric Oncology. 4th Ed, 2002
2. Pinkerton, Plowman: Paediatric Oncology. 2nd Ed. 1997
3. Paediatric clinics of North America, Aug 1997.Section 12: Hematology/Oncology

=== PAGE 817 ===

800 801
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 80: Approach to Severe Malnourished Children 
Chapter 81: Gastro-oesophageal Reflux Disease (GORD)
Chapter 82: Chronic Diarrhea  
Chapter 83: Functional Constipation in Children  1. Management of the child with a serious infection or severe malnutrition (IMCI). Unicef WHO 2000
2. Guidelines for the management of common childhood illness, 2nd ed. Chapter 7.1 Severe acute 
malnutrition WHO 2013
1. Rosen R etal. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of 
the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European 
Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018 
Mar;66(3):516-554.
1. Wylie R, Hyams JS, Kay M. Pediatric Gastrointestinal and Liver Disease, 5e. Saunders Elsivier, 2016.
2. Auth MKH, et al., Investigation of chronic diarrhea, Paediatrics and Child Health (2016)
3. Garrett C. Zella, Esther J. Israel,  Chronic Diarrhea in Children, Pediatrics in Review May 2012, 33 (5) 207-
218
4. Thiagarajah et al. Advances in Evaluation of Chronic Diarrhea in Infants. Gastroenterology 
2018;154:2045–2059
1. Tabbers MM, DiLorenzo C, Berger MY , Faure C, Langendam MW, Nurko S, Staiano A, Vandenplas Y , 
Benninga MA. Evaluation and treatment of functional constipation in infants and children: evidence-
based recommendations from ESPGHAN and NASPGHAN. Journal of pediatric gastroenterology and 
nutrition. 2014 Feb 1;58(2):258-74.
2. Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Childhood functional 
gastrointestinal disorders: child/adolescent. Gastroenterology. 2016 May 1;150(6):1456-68.
3. Benninga MA, Nurko S, Faure C, Hyman PE, Roberts IS, Schechter NL. Childhood functional 
gastrointestinal disorders: neonate/toddler. Gastroenterology. 2016 May 1;150(6):1443-55.
4. Bardisa-Ezcurra L, Ullman R, Gordon J. Diagnosis and management of idiopathic childhood constipation: 
summary of NICE guidance. BMj. 2010 Jun 1;340.
5. Shann, Frank. (2017-2020). Drug Doses 17th ed.
6. BNF Children. September 2019-2020. BMJ Group and the Royal Pharmaceutical Society of Great Britain.
7. Oxford Specialist Handbook of Paediatric Gastroenterology, Hepatology, and Nutrition.Second Edition 
2018
8. Pall H, Zacur GM, Kramer RE, Lirio RA, Manfredi M, Shah M, Stephen TC, Tucker N, Gibbons TE, Sahn B, 
McOmber M. Bowel preparation for pediatric colonoscopy: report of the NASPGHAN endoscopy and 
procedures committee. Journal of Pediatric Gastroenterology and Nutrition. 2014 Sep 1;59(3):409-16.
9. Nurko S, Zimmerman LA. Evaluation and treatment of constipation in children and adolescents. 
American family physician. 2014 Jul 15;90(2):82-90.
10. UpToDate, Chronic functional constipation and fecal incontinence in infants, children and adolescents: 
Treatment, 2022 Sep 15
11. UpToDate, Patient education: Constipation infants and children (Beyond the Basics), 2021 Nov 12Section 13: Gastroenterology

=== PAGE 818 ===

802
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 84: Prolonged Jaundice and Neonatal Cholestasis
Chapter 85: Evaluation and Management of Children with Liver Disease
Chapter 86: Approach to Gastrointestinal Bleeding1. R.Fawaz et al, JPGN Volume 64, Number 1, January 2017 Guideline for the Evaluation of Cholestatic 
Jaundice in Infants 
2. A.G. Feldman Semin Pediatr Surg. 2020 August; 29(4): 150945 “Recent Developments in diagnostics and 
treatment of neonatal cholestasis”
3. Dani et al. Italian guidelines for the management and treatment of neonatal cholestasis Italian Journal 
of Pediatrics (2015) 41:69
4. T. Götze et al, Front. Pediatr., 17 June 2015 Sec. Pediatric Gastroenterology, Hepatology and Nutrition
5. P . Quelhas, Protocols of Investigation of Neonatal Cholestasis— A Critical Appraisal , Healthcare 2022, 
10, 2012 
6. Jaundice in newborn babies under 28 days.NICE Clinical guideline [CG98]. Published: 19 May 2010. Last 
updated: 26 October 2016
1. J.E. Squires et al, Journal of Pediatric Gastroenterology and Nutrition 2022; 74:138-158 
2. S.A Taylor and PF Whitington, Liver Transplantation 2016; 22: 677-685.
3. Protokol Pengurusan Kes Hepatitis Akut Tidak Diketahui Penyebabnya (Acute Hepatitis of Unknown 
Aetiology) dalam Kalangan Kanak Kanak (Lampiran 3) (May 2022, MOH Malaysia)
4. Di Giorgio et al, Digestive and Liver Disease 2021 ;53(5): 545–557 
5. M.A. Leonis  GASTROENTEROLOGY 2008;134:1741–1751
6. S. Guandalini, A, Dhawan, Textbook of Pediatric Gastroenterology, Hepatology and Nutrition A 
Comprehensive Guide to Practice Second Edition Springer (2021)
1. Assessment and Management of Oesophageal Varices in Children Joint Guideline of the Children’s 
specialized Liver Services at King’s, Birmingham, and Leeds 2021.

=== PAGE 819 ===

802 803
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 87: Paediatric HIV 
Chapter 88: Malaria
Chapter 89: Tuberculosis  
Chapter 90: BCG Lymphadenitis  1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and 
preventing HIV infection: recommendations for a public health approach – 2nd ed. (2016)
2. Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the 
Use of Antiretroviral Agents in Pediatric HIV Infection. April 27, 2017.
3. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. 
Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal 
Health and Interventions to Reduce Perinatal HIV Transmission in the United States. 2016.
4. Bamford A, Turkova A, Lyall EGH, et al. on behalf of PENTA. Paediatric European Network for Treatment 
of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in 
preparation for adult life. HIV Med. 2015 Feb 3.
1. WHO Malaria treatment Guidelines Nov 2022.
2. Dondorp A, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African 
children (AQUAMAT): on open-label, randomized trial; Lancet 2010 Nov 13:376(9753): 1647-1657
3. Malaysia Malaria Guideline 2013.
4. NHSGGC Malaria treatment guidelines in Paediatrics 2021
5. Lalloo DG et al. UK malaria treatment guidelines.  J infect. 2016 Jun;72(6):63549
6. Matthew Grigg et al; Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax 
Malaria in Malaysia: An open label, randomized controlled trial, Clinical Infectious Diseases, Volume 62, 
Issue 11, 1 June 2016 Pages 1403-1411.
1. RAPID ADVICE. Treatment of tuberculosis in Children WHO/HTM/TB/2010.13.
2. Loeffler A, Curry FJ. Pediatric Tuberculosis: An Online Presentation. National Tuberculosis Center.
3. Guidelines for the Investigation of Contactsof Persons with Infectious TuberculosisRecommendations 
from the National Tuberculosis Controllers Association and CDC. MMWR Recommendations and 
Reports. December 16, 2005 / Vol. 54 / No. RR-15
4. Communicable Diseases Network Australia CDNA NATIONAL GUIDELINES FOR THE PUBLIC HEALTH 
MANAGEMENT OF TB July 2013
1. Singha A, Surjit S, Goraya S, Radhika S et al. The natural course of non-suppurative Calmette-Guerin 
bacillus lymphadenitis. Pediatr Infect Dis J 2002:21:446-448
2. Goraya JS, Virdi VS. Treatment of Calmette-Guerin bacillus adenitis, a metaanalysis. Pediatr Infect Dis J 
2001;20:632-4 (also in Cochrane Database of Systematic Reviews 2004; Vol 2.)
3. Banani SA, Alborzi A. Needle aspiration for suppurative post-BCG adenitis. Arch Dis Child 1994;71:446-7.Section 14: Infectious Disease

=== PAGE 820 ===

804
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 91: Dengue Viral Infection
Chapter 92: Diphtheria
Chapter 93: Congenital Syphilis
Chapter 94: Paediatric COVID-191. World Health Organization: Dengue Hemorrhagic Fever: Diagnosis,Treatment, Prevention and Control. 
Third Edition. Geneva. World Health Organization, TDR 2009.
2. Clinical Practice Guidelines Management of Dengue in Children, 2nd Edition, MOH/P/PAK/443.20(GU)-e, 
2020
3. Suchitra R, Niranjan K; Dengue hemorrhagic fever and shock syndromes.Pediatr Crit Care Med 2011 
Vol.12, No.1; 90-100.
1. Diphtheria Disease Management and Investigative Guidelines, Kansas Disease Investigation Guideline 
Version 03/2009.
2. CDC Epidemiology and Prevention of Vaccine Preventable Diseases, 14th Edition August 2021. Chapter 
7: Diphtheria. 
1. Rochelle PW, Debra H, Daniel BJ , et al. Centre for Diseases Control, Sexually Transmitted Infections 
Guidelines, 2021. MMWR Recomm Rep 2021; 70(No.4: page 51-54)
1. RW Peeling , et al. Diagnostics for COVID-19: Moving from pandemic response to control, 2022. The 
Lancet 399: 758-62.

=== PAGE 821 ===

804 805
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 95: Atopic Dermatitis 
Chapter 96: Common Cutaneous Infections1. NICE guideline for treatment of Atopic Dermatitis in children from birth to 12 years old. 2007
2. Kerscher M, Williams S, Lehmann P . Topical Treatment with Glucocorticoids. J Am Acad Dermatol 2006
3. Bieber B, Atopic Dermatitis. Ann Dermatol 2010
4. Simpson EL, Hanifin JM. Atopic dermatitis. J Am Acad Dermatol 2005.
1. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious 
Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP) . https://www.cdc.
gov/poxvirus/molluscum-contagiosum/clinical_information.html
2. Bugert, J.J., Alikhan, A. and Shwayder, T. (2019). Molluscum Contagiosum. In Harper’s Textbook of 
Pediatric Dermatology (eds P . Hoeger, V. Kinsler, A. Yan, J. Harper, A. Oranje, C. Bodemer, M. Larralde, D. 
Luk, V. Mendiratta and D. Purvis). https://doi.org/10.1002/9781119142812.ch48
3. Paller A Mancini AJ. Hurwitz Clinical Pediatric Dermatology : A Textbook of Skin Disorders of Childhood 
and Adolescence. Fifth ed. Edinburgh: Elsevier; 2016.
4. Meza-Romero R, Navarrete-Dechent C, Downey C. Molluscum contagiosum: an update and review 
of new perspectives in etiology, diagnosis, and treatment. Clin Cosmet Investig Dermatol. 2019 May 
30;12:373-381. doi: 10.2147/CCID.S187224. PMID: 31239742; PMCID: PMC6553952.
5. Gerlero P , Hernández-Martín Á. Actualización sobre el tratamiento de moluscos contagiosos en los ni 
̃nos. Actas Dermosifiliogr. 2018;109:408---415.
6. Pope M, Kyriakides K, Hoffman C (2020) Treatment of Warts in Pediatrics: A Review. J Fam Med Dis Prev 
6:132. doi.org/10.23937/2469-5793/1510132.
7. C. Gooptu, C. R. Higgins, M. P . James, Treatment of viral warts with cimetidine: an open-label study, 
Clinical and Experimental Dermatology, Volume 25, Issue 3, 1 May 2000, Pages 183–185, https://doi.
org/10.1046/j.1365-2230.2000.00608.x
8. Singal A, Grover C. Efficacy and Safety of Intralesional Bleomycin in the Management of Ungual Warts. 
Skin Appendage Disord. 2020 Nov;6(6):346-350. doi: 10.1159/000510989. Epub 2020 Oct 14. PMID: 
33313049; PMCID: PMC7706492.
9. Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014 
Aug 15;90(4):229-35. PMID: 25250996.
10. MIMS Malaysia (2019). Tinea Capitis. In MIMS Online. https://www.mims.com/malaysia/
11. Andrews MD, Burns M. Common tinea infections in children. Am Fam Physician. 2008 May 
15;77(10):1415-20. PMID: 18533375.
12. Chen X, Jiang X, Yang M, González U, Lin X, Hua X, Xue S, Zhang M, Bennett C. Systemic antifungal 
therapy for tinea capitis in children. Cochrane Database of Systematic Reviews 2016, Issue 5. Art. No.: 
CD004685. DOI: 10.1002/14651858.CD004685.pub3.
13. Gupta, A.K., Mays, R.R., Versteeg, S.G., Piraccini, B.M., Shear, N.H., Piguet, V., Tosti, A. and Friedlander, 
S.F. (2018), Tinea capitis in children: a systematic review of management. J Eur Acad Dermatol Venereol, 
32: 2264-2274. https://doi.org/10.1111/jdv.15088Section 15: Dermatology

=== PAGE 822 ===

806
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 97: Infantile Haemangiomas  
Chapter 98: Scabies
Chapter 99: Stevens-Johnson Syndrome1. Chang LC. Growth Characteristics of Infantile Hemangiomas: Implications for Management. Pediatrics 
2008 Aug;122(2):360-7
2. Krowchuk DP . Clinical Practice Guideline for the Management of Infantile Hemangiomas Pediatrics. 2019 
Jan;143(1):e20183475
3. Chiller KG. Hemangiomas of Infancy: Clinical Characteristics, Morphologic Subtypes, and Their 
Relationship to Race, Ethnicity, and Sex. Arch Dermatol. 2002 Dec;138(12):1567-76
4. Propranolol for haemangiomas of infancy. British Association of Dermatology. June 2018
5. Drolet BA, Frommelt PC, Chamlin SL, et al. Initiation and use of propranolol for infantile hemangioma: 
report of a consensus conference. Pediatrics. 2013;131(1):128–140 
6. Landells I. Treatment of Hemangiomas in Children. Skin Therapy Lett. 2001 Oct;6(11):3-5 
1. Communicable Disease Management Protocol – Scabies November 2, 2010 
2. United Kingdom National Guideline on the Management of Scabies infestation (2016)
3. Guidelines for management of scabies in Adults and Children MOH 2015

=== PAGE 823 ===

806 807
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 100: Diagnosis and Management of Inborn Error of Metabolism
1. Inborn Metabolic Diseases: Diagnosis and Treatment. 7th Edition. Editors: Jean-Marie Saudubray, 
Matthias R. Baumgartner, Angeles Garcia-Cazorla, John Walter. Publisher: Springer-Verlag Berlin and 
Heidelberg GmbH & Co. (2022)
2. 5th edition of ‘Vademecum Metabolicum’, a Metabolic handbook. Editors: Johannes Zschocke and 
Georg Hoffmann. Publisher: Thieme. (2020)
3. Diagnosis and Management of Mitochondrial Disorders. Editors: Michelangelo Mancuso, Thomas 
Klopstock. Publisher: Springer. (2019)
4. Nutrition Management of Inherited Metabolic Diseases: Lessons from Metabolic University. Editors: 
Laurie E. Bernstein,  Fran Rohr,  Joanna R. Helm. . Publisher: Springer. (2015)  
5. Barcelos I, Shadiack E, Ganetzky RD, Falk MJ. Mitochondrial medicine therapies: rationale, evidence, and 
dosing guidelines. Curr Opin Pediatr. 2020 Dec;32(6):707-718. doi: 10.1097/MOP .0000000000000954. 
PMID: 33105273; PMCID: PMC7774245.
6. Carelli V, Carbonelli M, de Coo IF, Kawasaki A, Klopstock T, Lagrèze WA, La Morgia C, Newman NJ, 
Orssaud C, Pott JWR, Sadun AA, van Everdingen J, Vignal-Clermont C, Votruba M, Yu-Wai-Man P , 
Barboni P . International Consensus Statement on the Clinical and Therapeutic Management of 
Leber Hereditary Optic Neuropathy. J Neuroophthalmol. 2017 Dec;37(4):371-381. doi: 10.1097/
WNO.0000000000000570. PMID: 28991104.
7. Ng YS, Bindoff LA, Gorman GS, Horvath R, Klopstock T, Mancuso M, Martikainen MH, Mcfarland R, 
Nesbitt V, Pitceathly RDS, Schaefer AM, Turnbull DM. Consensus-based statements for the management 
of mitochondrial stroke-like episodes. Wellcome Open Res. 2019 Dec 13;4:201. doi: 10.12688/
wellcomeopenres.15599.1. PMID: 32090171; PMCID: PMC7014928.
8. Saudubray JM, Mochel F, Lamari F, Garcia-Cazorla A. Proposal for a simplified classification of IMD 
based on a pathophysiological approach: A practical guide for clinicians. J Inherit Metab Dis. 2019 
Jul;42(4):706-727. doi: 10.1002/jimd.12086. Epub 2019 Apr 24. PMID: 30883825.
9. De Vries MC, Brown DA, Allen ME, Bindoff L, Gorman GS, Karaa A, Keshavan N, Lamperti C, McFarland 
R, Ng YS, O’Callaghan M, Pitceathly RDS, Rahman S, Russel FGM, Varhaug KN, Schirris TJJ, Mancuso 
M. Safety of drug use in patients with a primary mitochondrial disease: An international Delphi-based 
consensus. J Inherit Metab Dis. 2020 Jul;43(4):800-818. doi: 10.1002/jimd.12196. Epub 2020 Feb 7. 
PMID: 32030781; PMCID: PMC7383489.
10. Hsieh VC, Krane EJ, Morgan PG. Mitochondrial Disease and Anesthesia. Journal of Inborn Errors of 
Metabolism and Screening. 2017;5. doi:10.1177/2326409817707770Section 16: Genetic and Metabolic Disease

=== PAGE 824 ===

808
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 101: Common Genetic Syndromes
Chapter 102: Investigating Children Suspected Of Having A Condition With 
Genetic Basis1. The Down Syndrome Medical Interest Group (DSMIG UK and Ireland) evidence-based surveillance 
guidelines (2007 – 2020).
2. Marilyn J. Bull, Tracy Trotter, Stephanie L. Santoro, Celanie Christensen, Randall W. Grout, THE COUNCIL 
ON GENETICS; Health Supervision for Children and Adolescents With Down Syndrome. Pediatrics  May 
2022; 149 (5): e2022057010. 10.1542/peds.2022-057010.
3. Sothirasan K, Anand AJ, Chua MPW, Khoo PC, Chien Chua M. Clinical Guideline for 
Management of Down Syndrome in Singapore. Proceedings of Singapore Healthcare.  2022;31. 
doi:10.1177/20101058221104582.
4. Bull MJ. Down Syndrome. N Engl J Med. 2020 Jun 11;382(24):2344-2352. doi: 10.1056/NEJMra1706537. 
PMID: 32521135.
5. Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, Sherman SL, Reeves RH. Down 
syndrome. Nat Rev Dis Primers.  2020 Feb 6;6(1):9. doi: 10.1038/s41572-019-0143-7. PMID: 32029743; 
PMCID: PMC8428796.
6. Morris JK, Mutton DE, Alberman E. Revised estimates of the maternal age specific live birth prevalence 
of Down’s syndrome.  J Med Screen . 2002;9(1):2-6. doi: 10.1136/jms.9.1.2. PMID: 11943789.
7. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY , Greenberg F. Prader-Willi 
syndrome: consensus diagnostic criteria. Pediatrics. 1993 Feb;91(2):398-402. PMID: 8424017; PMCID: 
PMC6714046.
8. Ramsden SC, Clayton-Smith J, Birch R, Buiting K. Practice guidelines for the molecular analysis of Prader-
Willi and Angelman syndromes. BMC Med Genet. 2010 May 11;11:70. doi: 10.1186/1471-2350-11-70. 
PMID: 20459762; PMCID: PMC2877670.
9. Duis J, van Wattum PJ, Scheimann A, Salehi P , Brokamp E, Fairbrother L, Childers A, Shelton AR, Bingham 
NC, Shoemaker AH, Miller JL. A multidisciplinary approach to the clinical management of Prader-Willi 
syndrome. Mol Genet Genomic Med. 2019 Mar;7(3):e514. doi: 10.1002/mgg3.514. Epub 2019 Jan 29. 
PMID: 30697974; PMCID: PMC6418440.
10. McCandless, S. E., & Committee on Genetics (2011). Clinical report -health supervision for children with 
Prader -Willi syndrome. Pediatrics, 127(1), 195–204. https://doi.org/10.1542/peds.2010-2820 .
11. Miller JL, Lynn CH, Shuster J, Driscoll DJ. A reduced-energy intake, well-balanced diet improves weight 
control in children with Prader-Willi syndrome. J Hum Nutr Diet. 2013;26(1):2-9. doi:10.1111/j.1365-
277X.2012.01275.x
12. Deal, Cheri L et al. “Growth Hormone Research Society workshop summary: consensus guidelines 
for recombinant human growth hormone therapy in Prader-Willi syndrome.” The Journal of clinical 
endocrinology and metabolism vol. 98,6 (2013): E1072-87. doi:10.1210/jc.2012-3888
13. MSD Manual Professional Version Dec 2022. https://www.msdmanuals.com/professional
1. New Clinical Genetics, Fourth Edition by Andrew Read & Dian Donnai. Publisher: Scion (2021)
2. Inborn Metabolic Diseases: Diagnosis and Treatment. 7th Edition. Editors: Jean-Marie Saudubray, 
Matthias R. Baumgartner, Angeles Garcia-Cazorla, John Walter. Publisher: Springer-Verlag Berlin and 
Heidelberg GmbH & Co. (2022)
3. Oxford Desk Reference: Clinical Genetics and Genomics (2nd Edition) by Helen V. Firth and Jane A. 
Hurst. Publisher: Oxford University Press (2017)   
4. K. Manickam, M.R. McClain, L.A. Demmer, et al. Exome and genome sequencing for pediatric patients 
with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American 
College of Medical Genetics and Genomics (ACMG) Genet Med, 23 (11) (2021), pp. 2029-2037, 10.1038/
s41436-021-01242-6

=== PAGE 825 ===

808 809
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 103: Appendicitis
Chapter 104: Vomiting in the Neonate and Child
Chapter 105: Intussusception
Chapter 108: The Acute ScrotumChapter 106: Inguinal Hernias and Hydrocoele
Chapter 109: Penile ConditionsChapter 107: Undescended Testis1. Fyfe, AHB (1994) Acute Appendicitis, Surgical Emergencies in Children , Butterworth- Heinemann.
2. Anderson KD, Parry RL (1998) Appendicitis, Paediatric Surgery Vol 2, 5th Edition Mosby
3. Lelli JL, Drongowski RA et al: Historical changes in the postoperative treatment of appendicitis in 
children: Impact on medical outcome. J Pedi-atr. Surg 2000; 35:239-245.
4. Meier DE, Guzzetta PC, et al: Perforated Appendicitis in Children: Is there a best treatment? J Pediatr. 
Surg 2003; 38:1520-4.
5. Surana R, Feargal Q, Puri P: Is it necessary to perform appendicectomy in the middle of the night in 
children? BMJ 1993;306:1168.
6. Yardeni D, Coran AG et al: Delayed versus immediate surgery in acute appendicitis: Do we need to 
operate during the night? J Pediatr. Surg 2004; 39:464-9.
7. Chung CH, Ng CP , Lai KK: Delays by patients, emergency physicians and surgeons in the management of 
acute appendicitis: retrospective study HKMJ 2000; 6:254-9.
8. Mazziotti MV, et al: Histopathologic analysis of interval appendectomy specimens: support for the role 
of interval appendectomy. J Pediatr. Surg 1997; 32:806-809.
1. POMR Bulletin Vol 22 (Paediatric Surgery) 2004.
2. Navarro O,M et al. Intussusception: Use of delayed, repeated reduction attempts and the management 
of pathologic lead points in paediatric patients. AJR 2004; 182: 1169-76
3. Lui KW, et al. Air enema for the diagnosis and reduction of intussusception in children: Clinical 
experience and fluoroscopy time correlation. J Pediatr Surg 2001; 36:479-481
4. Calder F,R et al. Patterns of management of intussusception outside tertiary centres. J Pediatr Surg 
36:312-315, 2001.
5. DiFiore JW. Intussusception.Seminars in Paediatric Surgery 1999; 6:214-220
6. Hadidi AT, Shal N El. Childhood intussusception: A comparative study of nonsurgical management. J 
Pediatr Surg 1999; 34: 304-7
7. Fecteau et al: Recurrent intussusception: Safe use of hydrostatic enema. J Pediatr Surg 1996; 31:859-61
1. Gill B, Kogan S. Cryptorchidism (current concept). Paediatric Clinics of North America 1997; 44:1211-
1228.
2. O’Neill JA, Rowe MI, et al: Paediatric Surgery, Fifth Edition 1998Section 17: Paediatric Surgery

=== PAGE 826 ===

810
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 110: Neonatal Surgery
1. Congenital Diaphragmatic Hernia Registry (CDHR) Report, Seminars in Pediatric Surgery (2008) 17: 90-97
2. The Congenital Diaphragmatic Hernia Study Group. Defect size determines survival in CDH. Paediatrics 
(2007) 121:e651-7
3. Graziano JN. Cardiac anomalies in patients with CDH and prognosis: a report from the Congenital 
Diaphragmatic Hernia Study Group. J Pediatr Surg (2005) 40:1045-50
4. Hatch D, Sumner E and Hellmann J: The Surgical Neonate: Anaesthesia and Intensive Care, Edward 
Arnold, 1995
5. Vilela PC, et al: Risk Factors for Adverse Outcome of Newborns with Gastroschisis in a Brazilian hospital. 
J Pediatr Surg 2001; 36: 559-564,
6. Pierro A: Metabolism and Nutritional Support in the Surgical neonate. J Pediatr Surg 2002; 37: 811-822
7. Haricharan RN, Georgeson KE: Hirschsprung Disease. Seminars in Paediatric Surgery2008; 17(4): 266-
275
8. Waag KL et al: Congenital Diaphragmatic Hernia: A Modern Day Approach. Seminars in Paediatric 
Surgery 17(4): 244-254, 2008

=== PAGE 827 ===

810 811
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 106: Juvenile Idiopathic Arthritis
Chapter 107: Systemic Lupus Erythematosus1. Cassidy JT, Petty RE. Juvenile Rheumatoid Arthritis. In: Cassidy JT, Petty RE, eds. Textbook of Pediatric 
Rheumatology. 4th Edition. Philadelphia: W.B. Saunders Company, 2001.
2. Hull, RG. Management Guidelines for arthritis in children. Rheumatology 2001; 40:1308-1312
3. Petty RE, Southwood TR, Manners P , et al. International League of Associa- tions for Rheumatology. 
International League of Associations for Rheu- matology classification of juvenile idiopathic arthritis: 
second revision, Edmonton, 2001. J Rheumatol. 2004;31:390-392.
4. Khubchandani RP , D’Souza S. Initial Evaluation of a child with Arthritis – An Algorithmic Approach. 
Indian J of Pediatrics 2002 69: 875-880.
5. Ansell, B. Rheumatic disease mimics in childhood. Curr Opin Rheumatol 2000; 12: 445-447
6. Woo P , Southwood TR, Prieur AM, et al. Randomised, placebo controlled crossover trial of low-dose oral 
Methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 2000; 43: 
1849-57.
7. Alsufyani K, Ortiz-Alvarez O, Cabral DA, et al. The role of subcutaneous administration of methotrexate 
in children with JIA who have failed oral methotrexate. J Rheumatol 2004; 31 : 179-82
8. Ramanan AV, Whitworth P , Baildam EM. Use of methotrexate in juvenile idiopathic arthritis. Arch Dis 
Child 2003; 88: 197-200.
9. Szer I, Kimura Y , Malleson P , Southwood T. In: The Textbook of Arthritis in Children and Adolescents: 
Juvenile Idiopathic Arthritis. 1st Edition. Oxford University Press, 2006
10. Wallace, CA. Current management in JIA. Best Pract Res Clin Rheumatol 2006; 20: 279-300.
1. Levy DM, Kamphuis S. Systemic Lupus Erythematosus in Children and Adolescents. Pediatric Clinic of 
North Am. 2012 April; 59(2): 345-364
2. Thakral A, Kelin-Gitelman MS. An Update on Treatment and Management of Pediatric Systemic Lupus 
Erythematosus. Rheumatol Ther 2016; 3:209-219
3. Cassidy JT, Petty RE , Laxer RM, Lindsley CB (Eds). Textbook of Pediatric Rheumatology. 6th edition. 
Elsevier 2010.
4. Foster H, Brogan PA (Eds). Oxford Handbook in Paediatric Rheumatology. 1st edition, 2012
5. Mina R, Brunner HI. Pediatric Lupus - Are there differences in presentation, genetics, response to 
therapy, damage accrual compared to adult lupus? Rheum Dis Clin N Am 2010; 36: 53-80SECTION 18: RHEUMATOLOGY

=== PAGE 828 ===

812
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 113: Snake Bite
1. Ismail AK, Abd Hamid MNH, Ariff NA, Frederic Ng VER, Goh WC, et al. Frequency, clinical characteristics 
and outcomes of Tropidolaemus species bite envenomations in Malaysia. PLOS Neglected Tropical 
Diseases. 2023; 17(1): e0010983. 
2. Blessmann, J, Hanlodsomphou, S, Santisouk, B, Krumkamp, R, Kreuels, B, Ismail, AK, et al. Experience 
of using expired lyophilized snake antivenom during a medical emergency situation in Lao People’s 
Democratic Republic––A possible untapped resource to tackle antivenom shortage in Southeast Asia. 
Trop Med Int Health. 2023; 28(1): 64– 70. 
3. Ismail A.K., Teo E.W., Das I., Vasaruchapong T. & Weinstein S.A. Land Snakes of Medical Significance 
in Malaysia (3nd Edition). Forest Research Institute Malaysia, Ministry of Energy & Natural Resources, 
Putrajaya, Malaysia; 2022.
4. Ahmad Khaldun Ismail, Gregory Cham. Snake Related Injuries. In: Shirley Ooi, Matthew Low, Peter 
Manning (eds.), Guide to the Essentials in Emergency Medicine. 3rd ed. McGraw Hill; 2022. Chapter 96: 
622 – 631
5. Chanthawat Patikorn, Ahmad Khaldun Ismail, Syafiq Asnawi Zainal Abidin, Francis Bonn Blanco, Jörg 
Blessmann, Khamla Choumlivong, John David Comandante, Uyen Vy Doan, Zainalabidin Mohamed@
Ismail, Yi Yi Khine, Tri Maharani, Myat Thet Nwe, Reza Murad Qamruddin, Ruth Sabrina Safferi, 
Emelia Santamaria, Patrick Joseph G Tiglao, Satariya Trakulsrichai, Taksa Vasaruchapong, Nathorn 
Chaiyakunapruk, Suthira Taychakhoonavudh, Iekhsan Othman. Situation of snakebite, antivenom 
market and access to antivenoms in ASEAN countries. BMJ Global Health. 2022; 7(3): 1-27
6. Cheng-Hsuan Ho, Ahmad Khaldun Ismail, Shing-Hwa Liu, Yuan-Sheng Tzeng, Ling-Yuan Li, Feng-Cheng 
Pai, Chia-Wei Hong, Yan-Chiao Mao, Liao-Chun Chiang, Chin-Sheng Lin & Shih-Hung Tsai. The role of a 
point-of-care ultrasound protocol in facilitating clinical decisions for snakebite envenomation in Taiwan: 
a pilot study. Clinical Toxicology. 2021; 59(9): 794-800
7. Kae Yi Tan, Tzu Shan Nga, Aymeric Bourges, Ahmad Khaldun Ismail, Tri Maharani, Sumana Khomvilai, 
Visith Sitprija, Nget Hong Tan, Choo Hock Tan. Geographical variations in king cobra (Ophiophagus 
hannah) veno, m from Thailand, Malaysia, Indonesia and China: On venom lethality, antivenom 
immunoreactivity and in vivo neutralization. Acta Tropica. 2020. 203 105311
8. Tan CH, Tan KY , Ng TS, Quah ES, Ismail AK, Khomvilai S, Sitprija V, Tan NH. Venomics of Trimeresurus 
(Popeia) nebularis, the Cameron Highlands Pit Viper from Malaysia: Insights into Venom Proteome, 
Toxicity and Neutralization of Antivenom. Toxins. 2019; 11(2): 95
9. KY Tan, JL Liew, NH Tan, E Quah, AK Ismail, CH Tan. Unlocking the Secrets of Banded Coral Snake 
(Calliophis Intestinalis, Malaysia): A Venom with Proteome Novelty, Low Toxicity and Distinct 
Antigenicity. Journal of Proteomics. 2018; 192: 246-257SECTION 19: Poisons and Toxins

=== PAGE 829 ===

812 813
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 114: Common Poisons
1. Toxinz Database, National Poison Centre, New Zealand. ISSN 2624-344X 
2. Goldfrank’s Toxicologic Emergencies, 11th Edition, 2019 
3. WHO. World report on child injury prevention. http://www.who.int/ entity/violence_injury_prevention/
child/injury/world_report/en/index. Html
4. Evaluation of Types of Poisoning Exposure Calls Managed by the Malaysia National Poison Centre 
(2006-2015) : A Retrospective Review. Tangiisuran B, et al. BMJ Open 2018;8:e024162. doi:10.1136/
bmjopen-2018-024162 
5. Graudins A, et al. Overdose with modified-release paracetamol results in delayed and prolonged 
absorption of paracetamol. Intern Med J.  2010;40:72-76. 
6. Graudins A. Overdose with modified-release paracetamol (Panadol Osteo(R)) present¬ing to a 
metropolitan emergency medicine network: a case series. Emerg Med Australas . 2014;26:398-402. 
7. Berling I, et al. Intravenous paracetamol toxicity in a malnourished child. Clin Toxicol (Phila) . 2012;50:74-
76.
8. Gray T, et al. Intravenous paracetamol—an international perspective of toxicity. Clin Toxicol.  
2011;49:150-152.
9. McGovern AJ, et al. Can AST/ALT ratio indicate recovery after acute paracetamol poisoning? Clin Toxicol . 
2015;53:164-167.
10. Chyka PA, et al. Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital 
management. Clin Toxicol (Phila) . 2007;45:95-131.
11. Vertrees JE, et al. Repeated oral administration of activated charcoal for treating aspirin overdose in 
young children. Pediatrics . 1990;85:594-598. 
12. Broughton A, et al. Bilirubin interference with a salicylate assay performed on an Olympus analyser. A nn 
Clin Biochem . 2000;37(Pt 3):408-410. 
13. Berkovitch M, et al. False-high blood salicylate levels in neonates with hyperbilirubinemia. Ther Drug 
Monit.  2000;22:757-761. 
14. Chyka PA, et al. Salicylate poisoning: an evidence-based consensus guideline for out- of-hospital 
management. Clin Toxicol (Phila) . 2007;45:95-131. 
15. Cotton EK, Fahlberg VI. Hypoglycemia with salicylate poisoning. A report of two cases. Am J Dis Child.  
1964;108:171-173. 
16. Gaudreault P , et al. The relative severity of acute versus chronic salicylate poisoning in children: a 
clinical comparison. Pediatrics.  1982;70:566-569.  
17. Juurlink DN, et al. Extracorporeal treatment for salicylate poisoning: systematic review  and 
recommendations from the EXTRIP Workgroup. Ann Emerg Med.  2015;66:165-181.  
18. Utility of 2-Pyridine Aldoxime Methyl Chloride (2-PAM) for Acute Organophosphate Poisoning: A 
Systematic Review and Meta-Analysis J Med Toxicol 2018 Mar;14(1):91-98. doi: 10.1007/s13181-017-
0636-2. Epub 2017 Dec 11.
19. The Efficacy of Pralidoxime in the Treatment of Organophosphate Poisoning in Humans: A Systematic 
Review and Meta-analysis of Randomized Trials 2020 Mar 4;12(3):e7174. doi: 10.7759/cureus.7174.
20. Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in 
Adults. (Crit Care Med 2017; 45:e306–e315). DOI:10.1097/CCM.0000000000002087
21. Royal children’s hospital Melbourne Clinical practice guideline ethanol poisoning
22. Brent J, et al. Methanol poisoning in a 6-week-old infant.  J Pediatr. 1991;118(4, pt 1):644-646. 
23. EXTRIP guidelines in extracorporeal treatment in methanol poisoning National Clinical Toxicology Course  
Handbook 2022.
24. Geoffrey K et al. Management of Metformin-Associated Lactic Acidosis by Continuous Renal 
Replacement Therapy. PLoS ONE. August2011|Volume6|Issue8|e23200

=== PAGE 830 ===

814
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 115: Children And Young People’s Mental Health
1. Jeremy LG, Juan CC, Chronic stress and asthma in adolescents. Ann. Allergy Asthma Immunol. 2020. 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529939/pdf/nihms-1612064.pdf
2. Center for Paediatric Traumatic Stress. The D-E-F Framework for Trauma-Informed Pediatric Care. 
https://www.healthcaretoolbox.org/d-e-f-framework-trauma-informed-care
3. Center for Paediatric Traumatic Stress. Pocket Cards for D-E-F. https://www.healthcaretoolbox.org/sites/
default/files/images/pdf/DEFpocketcards.pdf
4. Center for Paediatric Traumatic Stress. Nursing Assessment tool. https://www.healthcaretoolbox.org/
sites/default/files/images/pdf/DEFNursingAssessmentFormFINAL.pdf
5. Canadian Paediatric Society. Mental Health: Screening tools and Rating Scales. https://cps.ca/en/
mental-health-screening-tools
6. Center for Youth Wellness. Adverse Childhood Experiences Questionaire and User Guide. https://
centerforyouthwellness.org/aceq-pdf/
7. Sunshine Academy. School Attendance Difficulties and School Related Trauma. https://sunshine-
support.org/school-attendance-difficulties-and-school-related-trauma/
8. Boris Birhamer MD. Screen for Child Anxiety Related Disorders (SCARED). Child Version. https://
www.aacap.org/App_Themes/AACAP/docs/member_resources/toolbox_for_clinical_practice_and_
outcomes/symptoms/ScaredChild.pdf
9. Boris Birhamer MD. Screen for Child Anxiety Related Disorders (SCARED). Parent Version. https://
www.aacap.org/App_Themes/AACAP/docs/member_resources/toolbox_for_clinical_practice_and_
outcomes/symptoms/ScaredParent.pdf
10. Galle-Tessonneau, M., Gana, K. School Refusal Evaluation (SCREEN). https://www.insa.network/images/
Georgines_uploads/SCREEN_English.pdf
11. Galle-Tessonneau, M., Gana, K. School Refusal Evaluation (SCREEN). User Manual. https://www.insa.
network/images/Georgines_uploads/User_Manual_SCREEN.pdf
12. Children Hospital of Eastern Ontario. Screening Tool: Obsessive Compulsive Disorder (OCD) (in Children 
and Youth). https://www.ementalhealth.ca/index.php?ID=14&m=survey
13. Shahid Ali et al. Conversion Disorder. Mind versus Body. A review. Innov Clin Neurosci. 2015;12(5–6):27–
33. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479361/pdf/icns_12_5-6_27.pdfSECTION 20: Child Psychiatry

=== PAGE 831 ===

814 815
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals                        REFERENCESChapter 116: Anaphylaxis
Chapter 117: Recognition and Assessment of Pain
Chapter 118: Sedation and Analgesia1. Sheikh A,Ten Brock VM, Brown SGA, Simons FER H1- antihistamines for the treatment of anaphylaxis 
with and without shock (Review) The Cochrane Library 2012 Issue 4
2. Advanced Paediatric Life Support: The practical approach 5th Edition 2011 Wiley- Blackwell; 279-289
3. Lee JK, Vadas P . Anaphylaxis: mechanism and management. Clinical & Experimental Allergy 2011 41, 
923-938
4. Estelle F, Simons R. Anaphylaxis and treatment. Allergy 2011; 66 (Suppl 99) 31-34
5. Choo KJL, Simons E, Sheikh A. Glucocorticoid for treatment of anaphyaxis: Cochrane systematic review. 
Allergy 2010; 65: 1205-1211
6. Graham RN, Neil HY . Anaphylaxis Medicine 2008; 37: 57-60
7. Tang MLK, Kang LW. Prevention and treatment of anaphylaxis. Paediatrics and Child Health 2008; 18: 
309-316
8. Clark S, Camargo CA Jr. Emergency treatment and prevention of insect- sting anaphylaxis. Current Opin 
Allergy Clin Immunol 2006; 6: 279-283
9. Emergency treatment of anaphylaxis reactions, APLS
1. Advanced Paediatric Life Support: The practical approach 5th Edition 2011 Wiley- Blackwell; 279-289SECTION 21: Paediatric Emergency Medicine

=== PAGE 832 ===

816
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
                        REFERENCESChapter 119: Practical Procedures
1. Advanced Life Support Group (ALSG). 2023. Advanced Paediatric Life Support: A Practical Approach to 
Emergencies, 7th edition. Wiley-Blackwell.  
2. American Heart Association. 2021. Textbook for Neonatal Resuscitation (NRP), 8th Edition.  
3. American Heart Association Textbook of Paediatric Advanced Life Support 2002. 
4. APLS - The Pediatric Emergency Medicine Resource. Gausche-Hill M, Fuchs S, Yamamoto L. 4th Edition 
2004, Jones and Bartlett Publishers.  
5. Edelmann CM Jr, Berstein J, Meadows R, et al (Eds) Paediatric Kidney Diseases 2nd edition. 1992
6. Forfar & Arneil’s Textbook of Paediatrics 5th edition:1829-1847
7. Laing IA, Dolye E 1998. Practical Procedures.
8. Walsh-Sukys MC, Krug SE. Procedures in infants and children. 1997 9. NRC Roberton 3rd Edition 1999. 
Iatrogenic disorders Chapter 37, pp 917938. Procedures Chapter 51, pp 1369-1384.
9. Postlethwaite RJ. Clinical Paediatric Nephrology 2nd edition.  1994
10. The Harriet Lane Handbook 17th Edition 2005, Procedures Chapter 3, pp 73-104. 
11. IM Balfour-Lynn et al. BTS Guidelines for the management of pleural infection I children. Thorax 2005:60 
(Supp1 1):i1-i21.
12. M Dufficy et al. Extravasation injury management for neonates and children: a systematic review and 
aggregated case series. J Hosp Med 2022;17:832-842.
13. Carlson D, Mowery B. Standards to prevent complications of urinary catheterization in children: should 
and should-knots. J Soc Pediatr Nurs 1997; 2: 37-41.
14. Smith AB, Adams LL. Insertion of indwelling urethral catheters in infants and children: a survey of 
current nursing practice. Pediatric Nurs 1998; 24: 229-234.
15. Ponka D, Baddar F. Top 10 forgotten diagnostic procedures: suprapubic bladder aspiration. Can Fam 
Physician. 2013 Jan;59(1):50.
16. Gochman RF, Karasic RB, Heller MB. Use of portable ultrasound to assist urine collection by suprapubic 
aspiration. Ann Emerg Med. 1991 Jun;20(6):631-5.
17. Barr L, Hatch N, Roque PJ, Wu TS. Basic ultrasound-guided procedures. Crit Care Clin. 2014 
Apr;30(2):275-304, vi. SECTION 22: PRACTICAL PROCEDURES

=== PAGE 833 ===

816 817
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals

=== PAGE 834 ===

818
PAEDIATRIC PROTOCOLS
5th Edition For Malaysian Hospitals
Kementerian Kesihatan Malaysia
Block E1, Parcel E,
Federal Government Administrative Centre,
62590 Putrajaya, Malaysia
Tel.: +603-8883 1047
http://www.moh.gov.my
